Evaluation of CSF-3 in Performing ECG

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

November 16, 2022

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions
HealthyECG
Interventions
DEVICE

CSF-3 watch, designed to monitor a user's heart rate based on ECG (electrocardiogram) and PPG (Photoplethysmograph) readings

The subjects will be connected to an ECG Holter, and an investigational Device will be placed simultaneously on the subject's wrist. All subjects in this phase will be asked to participate in a single continuous data recording measurement for seven (7) minutes

Trial Locations (1)

55102

Fairview Health Services, Minneapolis

All Listed Sponsors
lead

CardiacSense Ltd.

INDUSTRY